DMCC Speciality

Which are the latest news on DMCC Speciality?

Why is DMCC Speciality Chemicals Ltd falling/rising?

As of 05-Sep, DMCC Speciality Chemicals Ltd's stock price is declining at 293.80, down -0.71%, following a trend reversal after two days of gains. The stock has underperformed its sector and the broader market, with a significant drop in investor participation.

As of 05-Sep, DMCC Speciality Chemicals Ltd is experiencing a decline in its stock price, currently at 293.80, which represents a change of -2.1 or -0.71%. This decrease follows a trend reversal after two consecutive days of gains, indicating a shift in investor sentiment. Additionally, the stock has underperformed its sector by -0.61% today.<BR><BR>The stock's performance over the past week shows a decline of -2.36%, while the benchmark Sensex has only decreased by -0.97%. This suggests that DMCC is lagging behind the broader market. Furthermore, the stock has seen a significant drop in investor participation, with delivery volume falling by -32.76% compared to the 5-day average, indicating reduced interest from investors.<BR><BR>Despite trading above its moving averages across various time frames, the overall trend and recent performance suggest that DMCC Speciality Chemicals Ltd is currently facing downward pressure in its stock price.

Should I buy, sell or hold DMCC Speciality Chemicals Ltd?

Who are in the management team of DMCC Speciality?

The management team of DMCC Speciality includes Chairman Laxmikumar N Goculdas, Managing Director & CEO Bimal L Goculdas, and several independent directors, ensuring effective governance and oversight. Key members also include Whole-time Director Dilip Trimbak Gokhale and Vice Chairperson Mitika Laxmikumar Goculdas.

The management team of DMCC Speciality includes the following key members:<BR><BR>1. **Laxmikumar N Goculdas** - Chairman (Non-Executive)<BR>2. **Bimal L Goculdas** - Managing Director & CEO<BR>3. **Dilip Trimbak Gokhale** - Whole-time Director<BR>4. **Mitika Laxmikumar Goculdas** - Vice Chairperson<BR>5. **M T Ankleshwaria** - Independent Director<BR>6. **Sanjeev Vishwanath Joshi** - Independent Director<BR>7. **Mukul Manoharlal Taly** - Independent Director<BR>8. **Janaki Ashwin Patwardhan** - Independent Director<BR>9. **Omkar Chandrakant Mhamunkar** - Company Secretary & Compliance Officer<BR><BR>This team brings a mix of executive and independent oversight to the company, ensuring effective governance and management.

What does DMCC Speciality do?

DMCC Speciality Chemicals Ltd, established in 1919 and rebranded in 2022, operates in the specialty chemicals sector with a market cap of INR 742 Cr. As of June 2026, it reported net sales of 253 Cr and a net profit of 20 Cr, with a P/E ratio of 18.00.

Overview: <BR>DMCC Speciality Chemicals Ltd is a pioneer in the specialty chemicals industry and operates within the micro-cap market segment.<BR><BR>History: <BR>The company was incorporated in 1919 as 'Dharamsi Morarji Chemicals Company Limited' and changed its name to 'DMCC Speciality Chemicals Limited' on August 12, 2022. The most recent quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot: <BR>Net Sales: 253 Cr (Quarterly Results - Jun 2026) <BR>Net Profit: 20 Cr (Quarterly Results - Jun 2026) <BR>Market Cap: INR 742 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 18.00 <BR>Industry P/E: 43 <BR>Dividend Yield: 0.83% <BR>Debt-Equity: 0.33 <BR>Return on Equity: 11.01% <BR>Price to Book: 3.02<BR><BR>Contact Details: <BR>Address: Prospect Chambers, 317/21 Dr D N Road Fort Mumbai Maharashtra : 400001 <BR>Tel: 91-22-22048881/2/3 <BR>Email: dgokhale@dmcc.com <BR>Website: http://www.dmcc.com

Who are the peers of the DMCC Speciality?

DMCC Speciality's peers include Indo Amines, Fairchem Organic, Valiant Organics, and others, with varying management and growth risks. Chembond Chemic leads in 1-year returns at 40.64%, while DMCC Speciality has a return of -6.14%.

Peers: The peers of DMCC Speciality are Indo Amines, Fairchem Organic, Valiant Organics, Chembond Chemic., Chemcon Special., Jayant Agro Org., Kronox Lab, Black Rose Indus, and Vipul Organics.<BR><BR>Quality Snapshot: Excellent management risk is observed at Chembond Chemic., Chemcon Special., Kronox Lab, and Black Rose Indus, while Average management risk is found at Indo Amines, Fairchem Organic, Jayant Agro Org., and Vipul Organics. Below Average management risk is noted for Valiant Organics and Chemcon Special. In terms of Growth, Excellent growth is seen at Chembond Chemic. and Kronox Lab, while Average growth is found at Fairchem Organic, DMCC Speciality, and Vipul Organics. Below Average growth is observed at Indo Amines, Valiant Organics, Chemcon Special., Jayant Agro Org., and the rest. For Capital Structure, Excellent capital structure is noted at Chembond Chemic., Chemcon Special., Kronox Lab, and Black Rose Indus, while Good capital structure is found at Fairchem Organic and Jayant Agro Org., and Average capital structure is observed at DMCC Speciality and Vipul Organics.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Chembond Chemic. at 40.64%, while the peer with the lowest 1-year return is Indo Amines at -16.48%. DMCC Speciality's 1-year return is -6.14%, which is higher than Indo Amines but lower than Chembond Chemic. Additionally, no peers have a negative six-month return.

How big is DMCC Speciality?

As of 31st August, DMCC Speciality Chemicals Ltd has a market capitalization of 742.00 Cr, with recent net sales of 707.55 Cr and a net profit of 39.97 Cr. The company has shareholder's funds of 248.18 Cr and total assets of 444.24 Cr.

As of 31st August, DMCC Speciality Chemicals Ltd has a market capitalization of 742.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, DMCC Speciality reported Net Sales of 707.55 Cr and a Net Profit of 39.97 Cr.<BR><BR>For the reporting period of March 2026, the company has Shareholder's Funds amounting to 248.18 Cr and Total Assets of 444.24 Cr.

Are DMCC Speciality Chemicals Ltd latest results good or bad?

DMCC Speciality Chemicals Ltd's latest results show strong revenue growth of 41.86% year-on-year, but profitability concerns arise from a significant decline in operating margin and a low return on equity. While revenue is up, the company faces challenges in managing costs, warranting caution from investors.

The latest results for DMCC Speciality Chemicals Ltd present a mixed picture. On one hand, the company achieved a significant revenue growth of 41.86% year-on-year, reaching ₹177.64 crores in the March 2026 quarter, which is a record for the company. Additionally, net profit increased by 18.24% year-on-year to ₹7.65 crores, reflecting an improvement in profitability.<BR><BR>However, there are notable concerns regarding profitability metrics. The operating margin has contracted sharply from 12.08% in the same quarter last year to 9.96%, indicating rising costs and potential pricing pressures. This margin compression raises questions about the sustainability of the revenue growth, as it suggests that the company is facing challenges in managing its costs effectively.<BR><BR>Furthermore, the interest coverage ratio has deteriorated to 5.25 times, the lowest in recent quarters, which could impact the company's financial flexibility. The return on equity (ROE) stands at a relatively low 8.81%, indicating that the company is not generating strong returns on shareholder capital compared to its peers.<BR><BR>Overall, while DMCC has demonstrated strong revenue growth, the significant margin compression and weak return ratios suggest that the results are not entirely positive. Investors may need to be cautious and monitor how the company addresses these profitability challenges moving forward.

When is the next results date for DMCC Speciality Chemicals Ltd?

The next results date for DMCC Speciality Chemicals Ltd is 15 May 2026.

The next results date for DMCC Speciality Chemicals Ltd is scheduled for 15 May 2026.

Is DMCC Speciality technically bullish or bearish?

As of December 4, 2025, DMCC Speciality is in a bearish trend with strong indications of weakness, supported by bearish MACD readings, moving averages, and KST across multiple time frames.

As of 4 December 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with a strong indication of weakness. The weekly and monthly MACD readings are both bearish, reinforcing the negative outlook. The daily moving averages also confirm a bearish trend. Additionally, the KST is bearish on both weekly and monthly time frames, while the Bollinger Bands and OBV show mildly bearish conditions on the weekly. Overall, the combination of these indicators suggests a significant bearish sentiment for DMCC Speciality.

How has been the historical performance of DMCC Speciality?

DMCC Speciality's historical performance shows significant growth in net sales and profitability, with net sales rising from INR 327.95 crore in March 2024 to INR 431.30 crore in March 2025, and profit after tax increasing to INR 21.53 crore. However, rising raw material costs impacted overall expenditure, while total assets and liabilities remained stable.

Answer:<BR>The historical performance of DMCC Speciality shows a mixed trend across various financial metrics over the years.<BR><BR>Breakdown:<BR>DMCC Speciality's net sales increased significantly from INR 327.95 crore in March 2024 to INR 431.30 crore in March 2025, following a dip to INR 386.65 crore in March 2023. The total operating income mirrored this trend, reaching INR 431.30 crore in March 2025. However, raw material costs also rose to INR 259.09 crore in March 2025, up from INR 195.51 crore in March 2024, contributing to a total expenditure of INR 374.28 crore. This resulted in an operating profit (PBDIT) of INR 58.36 crore for March 2025, an increase from INR 46.71 crore in the previous year. Profit before tax also improved to INR 31.14 crore in March 2025, compared to INR 17.25 crore in March 2024, leading to a profit after tax of INR 21.53 crore. The company's earnings per share rose to INR 8.63 in March 2025 from INR 4.65 in March 2024. On the balance sheet, total assets increased to INR 371.92 crore in March 2025, while total liabilities were INR 371.92 crore, indicating a stable financial position. Cash flow from operating activities remained steady at INR 38 crore in March 2025, with a net cash inflow of INR 1 crore. Overall, DMCC Speciality demonstrated growth in sales and profitability, despite rising costs and fluctuating cash flows.

Is DMCC Speciality overvalued or undervalued?

As of November 19, 2025, DMCC Speciality is considered very attractive and undervalued compared to peers in the specialty chemicals sector, with favorable key ratios indicating strong growth potential despite a recent year-to-date return of -27.89%.

As of 19 November 2025, the valuation grade for DMCC Speciality has moved from attractive to very attractive, indicating a significant improvement in its perceived value. The company is currently considered undervalued, especially when compared to its peers in the specialty chemicals sector. Key ratios include a PE ratio of 23.89, an EV to EBITDA of 11.02, and a PEG ratio of 0.22, which suggests strong growth potential relative to its price.<BR><BR>In comparison with peers, DMCC Speciality's valuation stands out favorably against companies like Solar Industries, which has a PE ratio of 94.38, and Gujarat Fluoroch, with a PE ratio of 56.8, both categorized as very expensive. This stark contrast highlights DMCC's relative attractiveness in the market. Despite recent underperformance with a year-to-date return of -27.89% compared to the Sensex's 9.02%, the fundamental metrics suggest that DMCC Speciality is positioned well for future growth and recovery.

Who are the top shareholders of the DMCC Speciality?

The top shareholder of DMCC Speciality is Laxmikumar Narottam Goculdas, holding 36.27%, followed by individual investors with 33.75%. Other notable shareholders include Girish Gulati (HUF) at 2.28%, with minimal holdings from mutual funds (0.01%) and foreign institutional investors (1.16%).

The top shareholders of DMCC Speciality include Laxmikumar Narottam Goculdas, who holds the largest share at 36.27%. The company is primarily owned by promoters, with no pledged promoter holdings reported. Additionally, there are individual investors who collectively hold 33.75% of the shares. The highest public shareholder is Girish Gulati (HUF), with a holding of 2.28%. The company also has a small percentage of shares held by mutual funds (0.01%) and foreign institutional investors (1.16%) across six different entities.

Has DMCC Speciality declared dividend?

Yes, DMCC Speciality Chemicals Ltd has declared a 10% dividend, amounting to 1 per share, with an ex-date of August 28, 2024. While the company shows significant volatility in total returns over shorter periods, it has achieved a total return of 235.49% over the past five years.

DMCC Speciality Chemicals Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1<BR>- Ex-date: 28 Aug 24<BR><BR>Dividend Yield: 0.37%.<BR><BR>Total Returns by Period:<BR>Over the last 6 months, the price return was -29.58%, with a dividend return of 0%, resulting in a total return of -29.58%.<BR><BR>In the past year, the price return was -13.21%, the dividend return was 0.31%, leading to a total return of -12.9%.<BR><BR>Over two years, the price return was 4.57%, with a dividend return of 0.37%, resulting in a total return of 4.94%.<BR><BR>For the three-year period, the price return was -26.25%, the dividend return was 0.62%, culminating in a total return of -25.63%.<BR><BR>In the four-year timeframe, the price return was -18.72%, with a dividend return of 0.77%, leading to a total return of -17.95%.<BR><BR>Finally, over five years, the price return was 230.67%, the dividend return was 4.82%, resulting in a total return of 235.49%.<BR><BR>Overall, while DMCC Speciality has declared a dividend, the total returns over various periods show significant volatility, with a notable decline in returns over shorter periods, contrasting with strong returns over the longer five-year horizon.